Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00502814 · ClinicalTrials.gov registry record
3-Dimensional Form and Soft Tissue Biomechanics of the Breast
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- 45
- Enrollment target
NCT00502814: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT00502814 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00502814 was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to characterize the 3-dimensional form and mechanical properties of the breast. Researchers want to do this in order to develop new high technology tools for improving the diagnosis and treatment of breast cancer in women.
Interventions
- PROCEDURE 3-D Optical Surface Scan
- PROCEDURE Mechanical Testing
- PROCEDURE Cutaneous Ultrasound
- PROCEDURE Breast MRI and/or CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2003-01 |
| Est. Completion | 2011-10 |
Why NCT00502814 stopped before completion
NCT00502814 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which 3-D Optical Surface Scan is the first listed.
NCT00502814 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00502814 about?
NCT00502814 is a clinical study titled "3-Dimensional Form and Soft Tissue Biomechanics of the Breast". The goal of this clinical research study is to characterize the 3-dimensional form and mechanical properties of the breast. Researchers want to do this in order to develop new high technology tools for improving the diagnosis and treatment of breast cancer in women.
What is the current status of trial NCT00502814?
This trial is currently terminated. The enrollment target is 45 participants. The study started on 2003-01. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00502814?
The interventions under investigation include: 3-D Optical Surface Scan (PROCEDURE), Mechanical Testing (PROCEDURE), Cutaneous Ultrasound (PROCEDURE), Breast MRI and/or CT (PROCEDURE).
Who is sponsoring clinical trial NCT00502814?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia